Glencoe, MO, United States of America

Peter Q Olins


Average Co-Inventor Count = 10.2

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • Glencoe, MO (US) (1997 - 2002)
  • San Diego, CA (US) (2002)

Company Filing History:


Years Active: 1997-2002

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Peter Q Olins: Innovator in Hematopoiesis Research

Introduction

Peter Q Olins is a notable inventor based in Glencoe, MO (US). He has made significant contributions to the field of hematopoiesis through his innovative research and patents. With a total of 4 patents, Olins has focused on developing compositions that enhance blood cell production.

Latest Patents

Olins' latest patents include groundbreaking work on compositions for increasing hematopoiesis with interleukin-3 mutants. This invention relates to human interleukin-3 (hIL-3) variant or mutant proteins, which are functionally co-administered with other colony stimulating factors, cytokines, lymphokines, interleukins, and hematopoietic growth factors. Another significant patent involves the co-administration of interleukin-3 mutant polypeptides with colony stimulating factors for multi-lineage hematopoietic cell production, further emphasizing his focus on enhancing blood cell generation.

Career Highlights

Throughout his career, Olins has worked with reputable companies, including G.D. Searle & Company. His work has been instrumental in advancing the understanding and application of hematopoietic growth factors.

Collaborations

Some of his notable coworkers include S Christopher Bauer and Mark Allen Abrams. Their collaborative efforts have contributed to the success of various projects in the field.

Conclusion

Peter Q Olins stands out as an influential inventor in the realm of hematopoiesis research. His innovative patents and collaborations have significantly impacted the scientific community and continue to pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…